Research Presentation Sessions: Oncologic Imaging
RPS 116 - Predicting and monitoring response in oncology
Lectures
1
Early prediction of pathological response to neoadjuvant chemoradiotherapy for oesophageal cancer using fully hybrid PET/MR: updated results from interim analysis
07:00Alessandro Eugenio Pellegrini, Milan / IT
2
Reasons for discordance among imaging response criteria in lymphoma under CAR T-cell therapy
07:00Michael Winkelmann, Munich / DE
3
Monitoring patients with metastatic castration resistant prostate cancer using whole-body magnetic resonance imaging: comparison with conventional imaging
07:00Fabio Zugni, Milan / IT
4
Role of radiomics to predict patient outcome in metastatic gastroenteropancreatic neuroendocrine neoplasms
07:00Michela Polici, Rome / IT
5
Utility of 18F-FDG PET and MR-DWI datasets for the evaluation of treatment response of lymphoma patients to chemotherapy
07:00Johannes Grueneisen, Essen / DE
6
Predicting pathological response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: internal and external validation of a semi-quantitative model
07:00Thomas Van Den Berghe, Lochristi / BE
7
Lugano versus RECIL criteria in the assessment of treatment response in patients with large-cell B-diffuse lymphoma: preliminary single-centre results
07:00Nunzia Di Meglio, Siena / IT